These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3984694

  • 1. Intra-uterine pressure in dysmenorrhea.
    Lumsden MA, Baird DT.
    Acta Obstet Gynecol Scand; 1985; 64(2):183-6. PubMed ID: 3984694
    [Abstract] [Full Text] [Related]

  • 2. Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?
    Lumsden MA, Kelly RW, Baird DT.
    Prostaglandins; 1983 May; 25(5):683-92. PubMed ID: 6577521
    [Abstract] [Full Text] [Related]

  • 3. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O, Joelsson I.
    Acta Obstet Gynecol Scand; 1981 May; 60(3):229-32. PubMed ID: 7270089
    [Abstract] [Full Text] [Related]

  • 4. Pressure-velocity analysis of uterine muscle during spontaneous dysmenorrheic contractions in vivo.
    Smith RP.
    Am J Obstet Gynecol; 1989 Jun; 160(6):1400-3; discussion 1403-5. PubMed ID: 2735366
    [Abstract] [Full Text] [Related]

  • 5. The patterns of uterine contractility in normal menstruating women: from physiology to pathology.
    Bulletti C, DE Ziegler D, Setti PL, Cicinelli E, Polli V, Flamigni C.
    Ann N Y Acad Sci; 2004 Dec; 1034():64-83. PubMed ID: 15731300
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I, Hedner N, Mannheimer C.
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):123-9. PubMed ID: 8296814
    [Abstract] [Full Text] [Related]

  • 7. The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.
    Lundström V.
    Acta Obstet Gynecol Scand; 1977 Jan; 56(3):167-72. PubMed ID: 878858
    [Abstract] [Full Text] [Related]

  • 8. [Influence of naloxone on uterine contractions in patients with primary dysmenorrhea].
    Mrugacz G, Grygoruk C, Sieczyński P, Grusza M, Pietrewicz P, Pietrzycki B.
    Pol Merkur Lekarski; 2013 Sep; 35(207):151-3. PubMed ID: 24224452
    [Abstract] [Full Text] [Related]

  • 9. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.
    Henzl MR, Ortega-Herrera E, Rodriguez C, Izu A.
    Am J Obstet Gynecol; 1979 Oct 15; 135(4):455-60. PubMed ID: 484644
    [Abstract] [Full Text] [Related]

  • 10. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
    Ekström P, Juchnicka E, Laudanski T, Akerlund M.
    Contraception; 1989 Jul 15; 40(1):39-47. PubMed ID: 2505970
    [Abstract] [Full Text] [Related]

  • 11. Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain.
    Cockrum RH, Tu FF, Kierzkowska O, Leloudas N, Pottumarthi PV, Hellman KM.
    Am J Obstet Gynecol; 2024 May 15; 230(5):553.e1-553.e14. PubMed ID: 38295969
    [Abstract] [Full Text] [Related]

  • 12. The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea.
    Hauksson A, Ekström P, Juchnicka E, Laudański T, Akerlund M.
    Acta Obstet Gynecol Scand; 1989 May 15; 68(1):31-4. PubMed ID: 2801028
    [Abstract] [Full Text] [Related]

  • 13. Distribution analysis of intrauterine pressure in nonpregnant dysmenorrheic women.
    Smith RP.
    Am J Obstet Gynecol; 1984 Jun 01; 149(3):271-3. PubMed ID: 6731505
    [Abstract] [Full Text] [Related]

  • 14. Analysis of uterine contractility after administration of the non-steroidal anti-inflammatory drug nimesulide.
    Pulkkinen M, Monti T, Macciocchi A.
    Acta Obstet Gynecol Scand; 1992 Apr 01; 71(3):181-5. PubMed ID: 1317639
    [Abstract] [Full Text] [Related]

  • 15. The effect of flurbiprofen and naproxen sodium on intra-uterine pressure and menstrual pain in patients with primary dysmenorrhea.
    Milsom I, Andersch B, Sundell G.
    Acta Obstet Gynecol Scand; 1988 Apr 01; 67(8):711-6. PubMed ID: 3074603
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandins and the non-pregnant uterus. The pathophysiology of primary dysmenorrhea.
    Pulkkinen MO.
    Acta Obstet Gynecol Scand Suppl; 1983 Apr 01; 113():63-7. PubMed ID: 6344545
    [Abstract] [Full Text] [Related]

  • 17. Effects of a vasopressin antagonist in women with dysmenorrhea.
    Valentin L, Sladkevicius P, Kindahl H, Broeders A, Marsal K, Melin P.
    Gynecol Obstet Invest; 2000 Apr 01; 50(3):170-7. PubMed ID: 11014949
    [Abstract] [Full Text] [Related]

  • 18. The objective evaluation of dysmenorrhea therapy.
    Smith RP, Powell JR.
    Am J Obstet Gynecol; 1980 Jun 01; 137(3):314-9. PubMed ID: 6990763
    [Abstract] [Full Text] [Related]

  • 19. Aspects of inhibition of myometrial hyperactivity in primary dysmenorrhea.
    Forman A, Ulmsten U, Andersson KE.
    Acta Obstet Gynecol Scand Suppl; 1983 Jun 01; 113():71-6. PubMed ID: 6134424
    [Abstract] [Full Text] [Related]

  • 20. Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea.
    Oladosu FA, Tu FF, Farhan S, Garrison EF, Steiner ND, Roth GE, Hellman KM.
    Am J Obstet Gynecol; 2018 Jul 01; 219(1):91.e1-91.e7. PubMed ID: 29733841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.